4//SEC Filing
Gudkov Andrei V 4
Accession 0001144204-11-016383
CIK 0001318641other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:38 PM ET
Size
8.8 KB
Accession
0001144204-11-016383
Insider Transaction Report
Form 4
Gudkov Andrei V
DirectorChief Scientific Officer
Transactions
- Award
Employee Stock Options (Right to Buy)
2011-03-21+149,609→ 149,609 totalExercise: $7.16From: 2011-03-21Exp: 2021-03-20→ Common Stock (149,609 underlying)
Holdings
- 37,500
Employee Stock Options (Right to Buy)
Exercise: $8.36From: 2007-04-06Exp: 2017-04-05→ Common Stock (37,500 underlying) - 137,250
Employee Stock Options (Right to Buy)
Exercise: $4.00From: 2008-02-04Exp: 2018-02-03→ Common Stock (137,250 underlying) - 105,000
Employee Stock Options (Right to Buy)
Exercise: $3.44From: 2010-05-18Exp: 2020-05-17→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]On March 21, 2011, with the approval of the Compensation Committee, Cleveland BioLabs, Inc. issued stock options to Mr. Gudkov per the 2010 Executive Compensation Plan.
Documents
Issuer
CLEVELAND BIOLABS INC
CIK 0001318641
Entity typeother
Related Parties
1- filerCIK 0001370083
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:38 PM ET
- Size
- 8.8 KB